- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03439579
Pilot Study of the HWL Program (HWL)
Pilot Study of the Home Weight Loss Program
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Weight Management Center currently offers a remotely delivered (smart phone, tablet, computer) program to assist patients with maintaining weight losses already achieved, which includes multi-channel self-monitoring and asynchronous individually recorded feedback from clinical staff. The goal of the presently proposed project is to build on this existing maintenance-focused program to create a remotely delivered, standalone behavioral weight loss intervention designed to help participants initiate the important dietary, physical activity (PA) and behavioral changes necessary to achieve weight loss. We recently developed the Home Weight Loss (HWL) program by repackaging existing clinical educational materials as instructional lifestyle change modules to be delivered remotely for participant weight loss
The aim of the proposed project are to pilot test the effects of the HWL program among a sample of overweight and obese adults (N=30). The digital platform currently used in the maintenance program will be used for the HWL program
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- aged 18-70 years
- BMI = 25.0- 40 kg/m2
- Internet access via desktop or laptop computer
- valid email address
- smart phone ownership
- women of childbearing potential must agree to use effective contraception during the study
Exclusion Criteria:
- currently dieting (>10-pound weight loss in past 3 months)
- another member of the household is participating in this pilot study
- inability to engage in physical activity
- inability to read and speak English
- diagnosis of diabetes (other than treated by diet alone),
- uncontrolled thyroid condition or other endocrine disorder
- major depressive disorder or other severe psychiatric disorder (e.g., bipolar disorder) within the past two years
- past suicide attempt
- current use of prescription or over-the-counter weight loss medications
- current/planned pregnancy
- drug and/or alcohol abuse
- use of steroid medication for more than 10 days in the past three months *implanted electronic devices
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Home weight loss program
Participants will be instructed to daily monitor their body weight, minutes of activity, number of steps, and calories consumed for the duration of the pilot study, and they will receive recorded individualized feedback on this self-monitored data from Weight Management Center clinicians (registered dietitians, exercise psychologists, and behavioral specialists).
|
Patient remote self-monitoring of diet, activity, and weight with clinician feedback provided remotely based on self-monitored data.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body weight change
Time Frame: 12 weeks
|
body weight change (kg) from pre-to post
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
changes in body weight as a percentage of start weight
Time Frame: 12 weeks
|
percent body weight change
|
12 weeks
|
changes in body mass index
Time Frame: 12 weeks
|
weight in kgs divided by height in meters squared to obtain BMI (kg/m^2)
|
12 weeks
|
program satisfaction
Time Frame: 12 weeks
|
program satisfaction obtained from multiple choice items developed by study staff.
Subjects are asked to rate their level of agreement with items assessing their satisfaction with the overall program, available responses range from extremely satisfied to not at all satisfied.
|
12 weeks
|
changes in body fat percentage
Time Frame: 12 weeks
|
changes in body fat percentage
|
12 weeks
|
changes in waist and hip measurements
Time Frame: 12 weeks
|
changes in waist and hip measurements
|
12 weeks
|
usability of program components
Time Frame: 12 weeks
|
examine usage of tracking components including step, exercise, diet, and weight tracking
|
12 weeks
|
changes in eating behavior scores
Time Frame: 12 weeks
|
use of the Eating Behavior Inventory (EBI).
This is a validated 26-item scale assessing eating and weight control behaviors.
Subjects indicate agreement with statements with reponse options ranging in values from 1 (never or hardly ever) to 5 (always or almost).
Higher values are indicative of those most associated with weight loss (e.g., self-monitoring caloric intake) and are therefore associated with better weight loss outcomes following behavioral weight management intervention.
|
12 weeks
|
changes in scores on the power of food scale
Time Frame: 12 weeks
|
use of the Power of Food Scale (PFS).
This is a validated 15-item scale with responses scored and ranging between 1 (do not agree) and 5 (strongly agree) with the statements.
Higher scores indicate less favorable outcomes, as higher scores indicate increased patient susceptibility to food in the environment.
|
12 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Patrick M O'Neil, PhD, Medical University of South Carolina
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00070941
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsNot yet recruitingOverweight and Obesity | Overweight, Childhood | Overweight, Infant
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Memorial Sloan Kettering Cancer CenterRecruitingObesity | Overweight | Overweight and Obesity | Obese | Overweight or ObesityUnited States
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
-
University of British ColumbiaTerminatedOverweight and ObesityCanada
-
National Taiwan University HospitalCompleted
Clinical Trials on Home weight loss program
-
University of North Carolina, Chapel HillCompletedOverweight and ObesityUnited States
-
Rush University Medical CenterCompleted
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Dana-Farber Cancer InstituteCompletedWeight Loss Program After Cancer DiagnosisUnited States
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI); Healthways, Inc.Completed
-
The Hospital of VestfoldRoede ASActive, not recruiting
-
University of South AlabamaAmerican Society for Metabolic and Bariatric SurgeryCompletedType 2 DiabetesUnited States
-
Stanford UniversityTerminatedOverweight | Miscarriage | Obese | Recurrent Pregnancy LossUnited States
-
The Miriam HospitalNational Heart, Lung, and Blood Institute (NHLBI)Unknown